Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115466212A reveals a green organocatalytic route for 2-trifluoromethylquinolines. Achieve high purity and cost efficiency in API manufacturing without metal catalysts.
Discover the patented aluminum powder catalytic method for triphenylchloromethane. Enhance supply chain reliability and reduce manufacturing costs with our advanced fine chemical solutions.
Patent CN114133320B enables efficient synthesis for chromane structures. Reduces steps and enhances supply chain reliability for pharmaceutical intermediates.
Novel Ni-catalyzed method for trifluoroethylation using cheap 2-chloro-1,1,1-trifluoroethane. Mild conditions, high yield, suitable for pharma intermediates.
Patent CN112979498A reveals a high-yield synthesis route for 3-fluoro-4-trifluoromethyl benzonitrile, offering cost reduction in API manufacturing and improved supply chain reliability.
Patent CN108774189A reveals catalyst-free synthesis. Enhances supply chain reliability and cost reduction in fine chemical intermediates manufacturing for global partners.
Patent CN109438402B discloses a green catalytic route for benzofuranone derivatives. High yield, low cost, scalable process ideal for pharmaceutical intermediates manufacturing.
Novel palladium complex enables meta-selective coupling in water. Reduces solvent costs and enhances supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110922350B reveals a green, metal-free route for C2-acyloxylation of oxindoles using KI/H2O2, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN107438594B reveals a straight-through process for high-purity laurolactam. Discover cost reduction in nylon 12 manufacturing and scalable lactam production.
Novel palladium-catalyzed coupling method delivers high-purity pharmaceutical intermediates with streamlined processing for cost-effective supply chain integration and scalable production capabilities.
Patent CN108084129B details a novel enantioselective Baeyer-Villiger oxidation for prostaglandin intermediates, offering high ee values and scalable manufacturing solutions.
Novel 2-step synthesis of Montelukast intermediate via Wittig and Pd-coupling. Reduces cost and steps for API manufacturing.
Patent CN116003211B reveals novel Suzuki coupling. Offers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing.
Patent CN111138315B reveals a scalable Ag-catalyzed route for cyanoalkyl quinones, replacing costly photocatalysis for efficient pharmaceutical intermediate manufacturing.
Novel copper-catalyzed radical coupling method for chiral 3-aminopiperidine. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel chiral zinc complexes for asymmetric cyanosilylation. Efficient synthesis from tetracyanoethylene offering cost-effective catalytic solutions for fine chemical manufacturing.
Patent CN112724168B details a novel chiral pyridine N,B-ligand enhancing iridium catalysis. Discover cost-effective synthesis and supply chain advantages for pharma.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Novel hydrogenation process reduces noble metal usage and improves purity for sitagliptin manufacturing, offering significant cost and supply chain advantages.